Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

9.160 +0.130 (+1.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,414,275
Open 9.100
Bid (Size) 9.160 (1)
Ask (Size) 9.180 (88)
Prev. Close 9.030
Today's Range 8.973 - 9.310
52wk Range 4.970 - 16.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
Dr. Hershberg is a current board member with over 25 years of experience as a physician, scientist, and entrepreneur 
From Recursion Pharmaceuticals
Via GlobeNewswire
2 Stocks That Could 10x by 2035
These stocks are very promising, but it's important to consider the downside, too. 
Via The Motley Fool

Performance

YTD
-7.19%
-7.19%
1 Month
+15.37%
+15.37%
3 Month
-31.49%
-31.49%
6 Month
+33.53%
+33.53%
1 Year
+5.77%
+5.77%

More News

Read More
Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A 'Terrific Spec'
Via Benzinga
A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Recursion Pharm Stock Sees Relative Strength Rating Rise To 84
Via Investor's Business Daily
Demystifying Recursion Pharmaceuticals: Insights From 4 Analyst Reviews
Via Benzinga
(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest
Via Benzinga
What's the Difference Between Biotech Stocks and TechBio Stocks?
Via The Motley Fool
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
The Next Drug You Take May be Designed By A.I.
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Recursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism
Via Benzinga
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
Via Talk Markets
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
GameStop, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
Via Benzinga
Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
From Recursion Pharmaceuticals
Via GlobeNewswire
Cathie Wood Is Buying This Under-the-Radar AI Stock
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
RXRX Stock Earnings: Recursion Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know
Via Benzinga
Nvidia Favorite SoundHound AI Delivers Beat-And-Raise Report
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
Via Talk Markets
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
From Recursion Pharmaceuticals
Via GlobeNewswire
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.